Pharmacologic and nonpharmacologic treatments of insomnia

Neurologic Clinics

Volumn 23, Issue 4, 2005, Pages 1149-1163

  Becker, Philip M ^a,b,c  

^a Sleep Medicine Associates of Texas PA   (United States)

^b PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; DOXEPIN; ESTAZOLAM; ESZOPICLONE; FLURAZEPAM; HYPERICUM PERFORATUM EXTRACT; HYPNOTIC AGENT; IMIPRAMINE; INDIPLON; LORAZEPAM; MELATONIN; OXAZEPAM; QUAZEPAM; SEDATIVE AGENT; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALERIAN; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE;

ANTICHOLINERGIC EFFECT; ANXIETY; BEHAVIOR; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CHRONICITY; CIRCADIAN RHYTHM; COGNITIVE THERAPY; COORDINATION; DISEASE CLASSIFICATION; DROWSINESS; DRUG DEPENDENCE; EXERCISE; FALLING; HUMAN; INSOMNIA; LIFESTYLE; MAJOR DEPRESSION; MEMORY DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PSYCHOTHERAPY; QUESTIONNAIRE; RELAXATION TRAINING; REVIEW; SEDATION; SIDE EFFECT; SMOKING; SOMNOLENCE; TRAFFIC ACCIDENT; WITHDRAWAL SYNDROME; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; HUMANS; HYPNOTICS AND SEDATIVES; IMAGERY (PSYCHOTHERAPY); RELAXATION TECHNIQUES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 27144458823     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2005.05.002     Document Type: Review

References (22)

1. D.J. Kupfer, and C.F. Reynolds Management of insomnia N Engl J Med 336 1997 341 346
2. M.T. Smith, M.L. Perlis, and A. Park Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia Am J Psychiatry 150 2002 5 11
3. M.M. Ohayon Epidemiology of insomnia: what we know and what we still need to learn Sleep Med Rev 6 2002 97 111
4. NHLBI Working Group on Insomnia. Bethesda (MD): NHLBI; September 1998. NIH publication no. 98-4088.
5. A.J. Spielman, L.S. Caruso, and P.B. Glovinsky A behavioral perspective on insomnia treatment Psychiatric Clin North Am 10 1987 541 553
6. P. Hauri, and S. Linde No more sleepless nights: a proven program to conquer insomnia 1996 Wiley New York
7. Bootzin R. Stimulus control treatment for insomnia. Proceedings of the 80th annual convention of the American Psychological Association 1972;7:395-6.
8. A.J. Spielman, P. Saskin, and M.J. Thorpy Treatment of chronic insomnia by restriction of time in bed Sleep 10 1987 45 56
9. C.A. Espie Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults Annu Rev Psychol 53 2002 215 243
10. K.L. Lichstein C.M. Morin Treatment of late-life insomnia 2000 Sage Publications Thousand Oaks (CA)
11. C.M. Morin, P.J. Hauri, and C.A. Espie Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review Sleep 22 1999 1134 1156
12. G.D. Jacobs, E.F. Pace-Schott, and R. Stickgold Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison Arch Intern Med 164 17 2004 1888 1896
13. P.J. Hauri Sleep hygiene, relaxation therapy, and cognitive interventions P.J. Hauri Case studies in insomnia 1991 Plenum Publishing New York 65 84
14. A.A. Borbely, and G. Youmbi-Balderer Effect of diphenhydramine on subjective sleep parameters and on motor activity during bedtime Int J Clin Pharmacol Ther Toxicol 26 1988 392 396
15. W.B. Mendelson A review of the evidence for the efficacy and safety of trazodone in insomnia J Clin Psychiatry 66 2005 469 476
16. E.N. Ringdahl, S.L. Pereira, and J.E. Delzell Jr. Treatment of primary insomnia J Am Board Fam Pract 17 2004 212 219
17. W.B. Mendelson, T. Roth, and J. Cassella The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium Sleep Med Rev 8 2004 7 17
18. M.J. Sateia, and P.D. Nowell Insomnia Lancet 364 2004 1959 1973
19. A.D. Krystal, J.K. Walsh, and E. Laska Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia Sleep 26 2003 793 799
20. J. Barbera, and C. Shaprio Benefit-risk assessment of zaleplon in the treatment of insomnia Drug Saf 28 2005 301 318
21. M.L. Perlis Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia J Clin Psychiatry 65 2004 1128 1137
22. C.M. Morin, L. Belanger, and C. Bastien Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse Behav Res Ther 43 2005 1 14